Documents to download

The first part of this briefing considers definitions of service user representation in health and social care services, sometimes known as patient and public involvement (PPI). Defining what constitutes PPI is difficult and the concept is contested. This has created problems with determining what effective patient involvement looks like. Despite this, the King’s Fund has observed that the idea of putting patients first and giving them a stronger voice in the operation of health and social care services had “become the favoured mantra of politicians and senior policy-makers in health”. However, the King’s Fund suggested that these kinds of policies had been undermined by a lack of clarity about what involving people in health meant and that the policy had not been prioritised.    

The second part of this briefing looks at Healthwatch England and its network of local Healthwatch organisations. Healthwatch was created by the Health and Social Care Act 2012 to be an “independent consumer champion for both health and social care”. Healthwatch replaced the previous system of Local Involvement Networks (LINks), which it was argued lacked power and were not representative. Healthwatch England and the local Healthwatch organisations have a number of statutory duties, such as promoting and supporting the involvement of local people in the commissioning, provision and scrutiny of local care services.

Healthwatch England was allocated £4.5 million in 2015/16 by the Government to fund core running costs and additional non-recurrent funding, while local Healthwatch received around £31.8 million in the same year. The organisation has recently conducted work into people’s experiences of the complaints system, and made a number of recommendations to improve the complaints process in the NHS and social care services. It has also been suggested that local Healthwatch organisations face a number of challenges, such as problems of capacity and resources, accountability, and representation.


Documents to download

Related posts

  • Medicinal and agrochemical products can be granted a Supplementary Protection Certificate, an intellectual property right associated with patents, to provide up to five years of additional rights and protections once their patents have expired. In order to apply for an SPC, a product must receive approval to be sold on the UK market. Under the Northern Ireland/Ireland Protocol, products to be sold in Northern Ireland must obtain approval under EU law, whilst products to be sold in the rest of the UK will obtain approval under UK law. Currently, this marketing authorisation is only given on a UK-wide basis. This regulation amends the market authorisation process to enable authorisations to be granted for the Northern Ireland market only and for the Great Britain market only.

  • There is currently a system for mutual recognition of health and social care qualifications within and between European Economic Area states and Switzerland. The UK has passed legislation amending its provisions in this area to take account of its exit from the EU. In recent agreements with Switzerland and the European Free Trade Area states, the UK committed to conditions for these countries which go further than the legislation that has already been passed. The European Qualifications (Health and Social Care Professions) (EFTA States) (Amendment etc.) (EU Exit) Regulations 2020 would implement these commitments.

  • The UK will no longer be part of EU reciprocal and cross-border healthcare arrangements after the transition period ends on 31 December 2020. However, some groups of people will retain rights after this under the terms of the withdrawal agreement. The Government made regulations in 2019 to deal with reciprocal and cross-border healthcare if the UK left the EU with no ‘divorce’ deal. It is now planning to update these regulations to reflect the withdrawal agreement.